16.10
0.63 (4.07%)
0.63 (4.07%)
Upgrade to Real-Time
Afterhours (Closed)
Low
14.51
High
33.00
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Kiniksa Pharmaceuticals Ltd | KNSA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.63 | 4.07% | 16.10 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 15.34 | 15.28 | 16.10 | 16.10 | 15.47 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 15.00 | 16.10 | 1.10 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,485 | 468,690 | $ 15.70 | $ 7,356,208 | 348,511 | 14.51 - 33.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:11:01 | 2 | $ 16.10 | USD |
Kiniksa Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.10B | 68.08M | 28.06M | $ - | $ - | -3.01 | -7.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | -100.00k | 0.30% |
Kiniksa Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KNSA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 16.15 | 16.94 | 15.12 | 15.91 | 546,553 | -0.05 | -0.31% |
| 1 Month | 19.10 | 19.24 | 15.12 | 17.18 | 586,760 | -3.00 | -15.71% |
| 3 Months | 20.06 | 24.70 | 15.12 | 20.05 | 565,807 | -3.96 | -19.74% |
| 6 Months | 18.32 | 24.70 | 14.55 | 19.06 | 451,205 | -2.22 | -12.12% |
| 1 Year | 18.07 | 33.00 | 14.51 | 19.43 | 403,882 | -1.97 | -10.9% |
| 3 Years | 24.45 | 33.00 | 5.01 | 17.84 | 244,242 | -8.35 | -34.15% |
| 5 Years | 24.45 | 33.00 | 5.01 | 17.84 | 244,242 | -8.35 | -34.15% |
Kiniksa Pharmaceuticals Description
| Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases.Its clinical-stage product candidates include Rilonacept, which is in Phase II clinical trials for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; and KPL-716, KPL-045, KPL-404 are other monoclonal antibodies. |
